News
OHSU’s HIV vaccine technology acquired by Bay Area biotech
January 25, 2017 /
A San Francisco-based biotech company has acquired vaccine research by Oregon Health & Science University scientists, marking a critical step toward commercialization of a promising HIV vaccine.
OHSU will become a shareholder in Vir. The university will also get royalties and other payments for products based on OHSU’s technology.
By Lynne Terry | The Oregonian/OregonLive
Full Story: http://www.oregonlive.com/health/index.ssf/2017/01/ohsus_hiv_vaccine_technology_a.html#incart_river_home
MATR Supporters (view all)
Posted in: Oregon Business
Sorry, we couldn't find any posts. Please try a different search.